Asia Pacific

Similar to the pattern seen in vitamins, sales of dietary supplements continue to see steady growth in current value terms in 2023 due to increasing health consciousness. The market has been hit by the rising cost of raw materials and production…

In 2023, dietary supplements is only set to see low current value growth, but will maintain the gains seen during the pandemic. Meanwhile, although retail volume sales are expected to decline in around half the categories, this is after seeing a peak…

Dietary supplements has been experiencing significant growth in India, primarily owing to the growing challenge of maintaining a balanced diet in the face of increasingly hectic and sedentary lifestyles. As the pace of life accelerates and work…

2023 saw increased interest in women’s health and beauty supplements in Hong Kong as pandemic restrictions were removed, with more opportunities for consumers to go out and socialise. Female consumers are increasingly attracted to supplements with…

Dietary supplements is expected to register robust growth in China in 2023, after the easing of COVID-19-related restrictions. The surge in COVID-19 cases since the lifting of restrictions in late December 2022 brought health products such a dietary…

In dietary supplements in Azerbaijan, sales are seeing positive though slowed volume sale growth in 2023, buoyed by fierce competition among market players. However, there is a regulatory hurdle that is curbing growth potential, in that the…

Despite another positive performance by dermatologicals in 2023, the category is recording significantly slower growth rates compared to 2022. The dynamic growth in 2022 was due to the fact that after the lifting of restrictions in Vietnam, local…

Retail sales of dermatologicals showed moderate growth in current value terms in 2023, with inflationary pressures less severe but still a factor. The dermatological category in Uzbekistan is an area lacking in development, largely due to the limited…

2023 saw rising demand for dermatologicals supported by the return to pre-pandemic daily routines and lifestyles as greater exposure to the causes of various mild skin conditions resulted in a higher incidence of skin infections and parasite-related…

Retail sales of dermatological products in Thailand experienced accelerated growth in current value terms in 2023, following the return of consumers to more active lifestyles outside the home. With this increased mobility came a greater risk of…

As is the case across consumer health in Taiwan, herbal/traditional varieties have continued to gain popularity in dermatologicals in 2023 amidst rising awareness of the potentially harmful side effects and contraindications of active pharmaceutical…

Dermatologicals is a saturated category in South Korea and has lost some of its growth momentum in terms of retail volume sales. A lack of new product development is one factor hampering stronger growth for some products, whilst another is increasing…

The social restrictions in Singapore at the start of the pandemic led to less time spent outside the home, and therefore less concern about looks. This contributed to volume and current value declines for hair loss treatments and medicated shampoos…

Skin diseases across all age groups continues to drive growth for dermatologicals. Skin diseases are common in rural areas due to poor hygiene and in urban areas due to overcrowded neighbourhoods, with many having no access to proper sanitary…

Dermatologicals saw an overall increase in demand in 2023, although performance varied somewhat by subcategory Nappy (diaper) rash treatments, for example, benefited from the return of consumers to more active lifestyles outside the home, which meant…

Over 2023, dermatologicals is expected to see fast retail current value growth across categories, supported by rising prices amid a highly inflationary climate. In retail volume terms, growth is set to be positive, if more moderate than in current…

Dermatologicals has seen a return to growth in current value terms in 2023, which is mainly due to the waning impact of COVID-19 on consumer lifestyles and behaviours. Antipruritics is one of the largest categories within dermatologicals and has also…

In Indonesia, according to data from the Indonesian Paediatrician Association (IDAI), around 7-35% of babies aged 6-12 months experience nappy (diaper) rash. With Indonesia’s population, that means between two million and 10 million babies suffer…

The above-average, high single-digit current value growth expected in topical germicidals/antiseptics in 2023 is also driving growth within overall dermatologicals in India, as this is the largest category. This surge in sales has been driven by…

Dermatologicals in Hong Kong saw continued positive growth in 2023. Steady growth in antifungals was driven by medicated shampoos, vaginal antifungals and other dermatologicals such as topical allergy remedies/antihistamines, with hair loss…

In the wake of the pandemic, marked by an increased emphasis on holistic health, skin health has experienced a robust resurgence in 2023. Forecasts indicate that dermatologicals is poised to achieve steady mid-single-digit current value growth in…

Dermatologicals in Azerbaijan is recording an upward trajectory in 2023 but at a pace that could generously be called moderate, and notably slower in terms of volume sales compared to 2022. When it comes to dermatologicals, local consumer education…

Vietnam has been experiencing a higher number of cases of influenza in 2023, which is benefiting sales of cough, cold and allergy (hay fever) remedies. Due to prolonged home seclusion as a result of pandemic-related restrictions, Vietnamese consumers…

Cough, cold and allergy remedies face favourable growth in 2023, with the category boosted by the return to normal social lifestyles post-pandemic. The regular circulation of seasonal cold viruses is fuelling demand, which had previously fallen due…

Cough, cold and allergy (hay fever) remedies continued to enjoy healthy growth in current value terms in 2023. This was driven, to a large extent, by the revival of normal pre-pandemic patterns of behaviour, including the return of Thais to their…

In the Philippines, one interesting aspect of OTC products in general and cough, cold and allergy (hay fever) remedies in particular is that consumers are generally very aware of the active ingredients that are contained within these products and the…

In line with rising health-consciousness, people in Taiwan are becoming more worried about the potentially hazardous side effects and contraindications of active pharmaceutical ingredients in standard OTC medications. This has continued to buoy…

Like analgesics, sales of cough, cold and allergy (hay fever) remedies continue to rise, benefiting from the “tripledemic” of rising COVID-19 cases, the stronger return of influenza due to greater mobility outside of the home and contact with others,…

The pandemic brought about a huge increase in sales of cough, cold and allergy (hay fever) remedies, especially from the end of 2021, with later COVID-19 variants being revealed to have unique symptoms resembling those of the common cold. In February…

As people become more aware of the importance of self-care, there is a growing demand for OTC medications to treat cough and cold. Access to healthcare is limited and as such it is easier to buy OTC medications. Therefore, despite the increase in…

Cough, cold and allergy (hay fever) remedies witnessed an improved performance in constant value terms in 2023. This was due, in a large part, to a return of pre-pandemic lifestyles, including the reopening of schools and workspaces, which…

Cough, cold and allergy (hay fever) remedies is experiencing a level of stabilisation in 2023. Following strong retail volume growth in the wake of the Coronavirus (COVID-19) pandemic, almost all categories are projected to see slower retail volume…

Sales of cough, cold and allergy (hay fever) remedies in Japan have continued to recover in 2023. This is largely due to increased opportunities for consumers to go out and a shift away from the practice of wearing face masks on a daily basis. With…

Although the pandemic is considered over, this is not expected to immediately reduce sales of OTC cough and cold medicines in Indonesia in 2023, with both retail volume and current value growth set to continue across most categories. However, the…

In 2023, cough, cold, and allergy (hay fever) remedies in India is set to experience moderate single-digit current value growth, driven predominantly by the demand for decongestants. Decongestants is expected to demonstrate above-average growth due…

The removal of mask-wearing and social distancing measures in March 2023 led to rising demand for cough, cold and allergy remedies as respiratory infections increased. Since February 2020, local seasonal influenza in Hong Kong has remained at a low…

Even though cough, cold and allergy (hay fever) remedies recorded over 40% current value growth in 2022, it is anticipated that the category will continue to achieve high single-digit growth in 2023. Starting from late 2022, the end of the zero-COVID…

As COVID-19 restrictions lift and society returns to face-to-face interaction, the regular seasonal sicknesses —colds and flus—are making their own return to Azerbaijan. More social mingling means not just handshakes and hugs on the rise; sniffling…

Current value sales of consumer health in Vietnam continue to record strong growth in line with the rising trend of health and wellness in the country. Post-pandemic, the majority of Vietnamese consumers are taking greater care of their health, and…

Consumer health in 2023 is exhibiting solid current value growth as the impact of the COVID-19 pandemic diminishes. With the resurgence of seasonal ailments, categories such as cough, cold and allergy (hay fever) remedies and analgesics are…

Positive sales growth was registered across most categories of consumer health in the Philippines in 2023 as the strong focus on health and wellbeing that has spread among the population since the peak of the COVID-19 pandemic continued to spur…

The market for consumer health products in Thailand continued to enjoy healthy growth in current value terms in 2023. This was driven, to a large extent, by the revival of normal pre-pandemic patterns of behaviour, including the return of consumers…

Consumer health in Taiwan has performed positively on the whole in 2023, with growth in total current value sales remaining robust and most categories either expanding in volume terms or contracting at a slower pace than in 2022. The easing of the…

During the pandemic Sri Lanka received international support to purchase the necessary medication to help them fight COVID-19. However, due to the current economic crisis the Government of Sri Lanka has had to impose import restrictions due to…

The self-medication trend is growing in South Korea, supporting further sales growth for analgesics, and cough, cold and allergy (hay fever) remedies, especially since the prevalence of the “tripledemic” in the country, consisting of COVID-19,…

With the threat of the pandemic leaving people’s minds in 2023, growth in consumer health in Singapore is set to stabilise, due to the gradual normalisation of consumers’ lives. With the majority of the population vaccinated, and COVID-19 likened to…

Pakistan’s economy continues to struggle and the government secured a further USD3 billion bailout with the IMF in July 2023, avoiding an impending default. Inflation continues to be very high and is being driven by several factors, including…

Consumers are increasingly adopting a preventative approach to maintaining good health, which continues to drive interest in vitamins and dietary supplements in 2023. Established brands continue to dominate sales as brand loyalty is relatively high…

Since the outbreak of COVID-19, Malaysian consumers have been increasingly focused on preventative health measures, and this trend continued into 2023. Alongside the adoption of healthier diets and exercise behaviours, consumers sought out vitamins…

In 2023, health sensitivities among consumers in Laos, due to local diet and weather, have led to increased demand for consumer health products. Likewise, the prevalence of self-medication persists due to limited hospital access, leading consumers to…